ROSY F (Fenofibrate (145mg) + Rosuvastatin (10mg))

Rosycap-F Tablet is formulated with a combination of two lipid-lowering agents. It serves the purpose of decreasing blood lipids, specifically cholesterol and triglycerides, particularly when dietary modifications, such as following a low-fat diet, are insufficient on their own. The use of this medication is aimed at mitigating the risk of developing heart-related conditions. It can be consumed either with food or on an empty stomach, enabling flexibility in timing, though it is advisable to take it consistently at the same time daily to aid in adherence to the regimen. The prescribing physician will determine the appropriate dosage based on individual lipid levels and patient response to the treatment. Many individuals with elevated cholesterol and triglyceride levels may not exhibit noticeable symptoms, but discontinuing the treatment can lead to a rise in lipid levels, exacerbating the condition and elevating the risk of heart disease and stroke. Regular monitoring of cholesterol and triglyceride levels is essential. This medication should be viewed as part of a broader treatment strategy that includes a healthy diet low in fats, consistent physical activity, quitting smoking, limiting alcohol intake, and achieving weight loss. While taking this medication, normal dietary habits can be maintained with an emphasis on minimizing high-fat food intake. Some individuals may experience mild side effects such as nausea, abdominal discomfort, constipation, headaches, increased gas, and muscle discomfort. These effects typically subside over time, but it is important to consult a healthcare provider if they persist or if any concerning symptoms arise, such as jaundice, unusual bleeding, or severe unexplained muscle aches. Periodic liver function tests may be recommended during the treatment. This medication is contraindicated in patients with liver conditions, such as those with abnormal liver function tests or jaundice. Prior to initiating treatment, it is essential to inform the healthcare professional about any kidney issues and whether there are plans for pregnancy or if breastfeeding is occurring. Diabetic patients are advised to monitor their blood glucose levels, as this medication may lead to increases in these levels.